Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106

S. Gourgou-Bourgade; D. Cameron; P. Poortmans; B. Asselain; D. Azria; F. Cardoso; R. A'Hern; J. Bliss; J. Bogaerts; H. Bonnefoi; E. Brain; M. J. Cardoso; B. Chibaudel; R. Coleman; T. Cufer; L. Dal Lago; F. Dalenc; E. De Azambuja; M. Debled; S. Delaloge; T. Filleron; J. Gligorov; M. Gutowski; W. Jacot; C. Kirkove; G. MacGrogan; S. Michiels; I. Negreiros; B. V. Offersen; F. Penault Llorca; G. Pruneri; H. Roche; N. S. Russell; F. Schmitt; V. Servent; B. Thürlimann; M. Untch; J. A. van der Hage; G. van Tienhoven; H. Wildiers; J. Yarnold; F. Bonnetain; S. Mathoulin-Pélissier; C. Bellera; T. S. Dabakuyo-Yonli

doi:10.1093/annonc/mdv478

Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106

S. Gourgou-Bourgade, D. Cameron, P. Poortmans, B. Asselain, D. Azria, F. Cardoso, R. A'Hern, J. Bliss, J. Bogaerts, H. Bonnefoi, E. Brain, M. J. Cardoso, B. Chibaudel, R. Coleman, T. Cufer, L. Dal Lago, F. Dalenc, E. De Azambuja, M. Debled, S. DelalogeT. Filleron, J. Gligorov, M. Gutowski, W. Jacot, C. Kirkove, G. MacGrogan, S. Michiels, I. Negreiros, B. V. Offersen, F. Penault Llorca, G. Pruneri, H. Roche, N. S. Russell, F. Schmitt, V. Servent, B. Thürlimann, M. Untch, J. A. van der Hage, G. van Tienhoven, H. Wildiers, J. Yarnold, F. Bonnetain, S. Mathoulin-Pélissier, C. Bellera, T. S. Dabakuyo-Yonli

Résultats de recherche: Contribution à un journal › !!Comment/debate

28 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	2505
Nombre de pages	1
journal	Annals of Oncology
Volume	26
Numéro de publication	12
Les DOIs	https://doi.org/10.1093/annonc/mdv478
état	Publié - 1 déc. 2015

Accès au document

10.1093/annonc/mdv478

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Gourgou-Bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F., A'Hern, R., Bliss, J., Bogaerts, J., Bonnefoi, H., Brain, E., Cardoso, M. J., Chibaudel, B., Coleman, R., Cufer, T., Dal Lago, L., Dalenc, F., De Azambuja, E., Debled, M., ... Dabakuyo-Yonli, T. S. (2015). Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106. Annals of Oncology, 26(12), 2505. https://doi.org/10.1093/annonc/mdv478

Gourgou-Bourgade, S. ; Cameron, D. ; Poortmans, P. et al. / Erratum : Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106. Dans: Annals of Oncology. 2015 ; Vol 26, Numéro 12. p. 2505.

@article{cd578b8500674061a9d1849d3d88ab87,

title = "Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106",

author = "S. Gourgou-Bourgade and D. Cameron and P. Poortmans and B. Asselain and D. Azria and F. Cardoso and R. A'Hern and J. Bliss and J. Bogaerts and H. Bonnefoi and E. Brain and Cardoso, {M. J.} and B. Chibaudel and R. Coleman and T. Cufer and {Dal Lago}, L. and F. Dalenc and {De Azambuja}, E. and M. Debled and S. Delaloge and T. Filleron and J. Gligorov and M. Gutowski and W. Jacot and C. Kirkove and G. MacGrogan and S. Michiels and I. Negreiros and Offersen, {B. V.} and {Penault Llorca}, F. and G. Pruneri and H. Roche and Russell, {N. S.} and F. Schmitt and V. Servent and B. Th{\"u}rlimann and M. Untch and {van der Hage}, {J. A.} and {van Tienhoven}, G. and H. Wildiers and J. Yarnold and F. Bonnetain and S. Mathoulin-P{\'e}lissier and C. Bellera and Dabakuyo-Yonli, {T. S.}",

year = "2015",

month = dec,

day = "1",

doi = "10.1093/annonc/mdv478",

language = "English",

volume = "26",

pages = "2505",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "12",

}

Gourgou-Bourgade, S, Cameron, D, Poortmans, P, Asselain, B, Azria, D, Cardoso, F, A'Hern, R, Bliss, J, Bogaerts, J, Bonnefoi, H, Brain, E, Cardoso, MJ, Chibaudel, B, Coleman, R, Cufer, T, Dal Lago, L, Dalenc, F, De Azambuja, E, Debled, M, Delaloge, S, Filleron, T, Gligorov, J, Gutowski, M, Jacot, W, Kirkove, C, MacGrogan, G, Michiels, S, Negreiros, I, Offersen, BV, Penault Llorca, F, Pruneri, G, Roche, H, Russell, NS, Schmitt, F, Servent, V, Thürlimann, B, Untch, M, van der Hage, JA, van Tienhoven, G, Wildiers, H, Yarnold, J, Bonnetain, F, Mathoulin-Pélissier, S, Bellera, C & Dabakuyo-Yonli, TS 2015, 'Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106', Annals of Oncology, VOL. 26, Numéro 12, p. 2505. https://doi.org/10.1093/annonc/mdv478

Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106. / Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P. et al.
Dans: Annals of Oncology, Vol 26, Numéro 12, 01.12.2015, p. 2505.

Résultats de recherche: Contribution à un journal › !!Comment/debate

TY - JOUR

T1 - Erratum

T2 - Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106

AU - Gourgou-Bourgade, S.

AU - Cameron, D.

AU - Poortmans, P.

AU - Asselain, B.

AU - Azria, D.

AU - Cardoso, F.

AU - A'Hern, R.

AU - Bliss, J.

AU - Bogaerts, J.

AU - Bonnefoi, H.

AU - Brain, E.

AU - Cardoso, M. J.

AU - Chibaudel, B.

AU - Coleman, R.

AU - Cufer, T.

AU - Dal Lago, L.

AU - Dalenc, F.

AU - De Azambuja, E.

AU - Debled, M.

AU - Delaloge, S.

AU - Filleron, T.

AU - Gligorov, J.

AU - Gutowski, M.

AU - Jacot, W.

AU - Kirkove, C.

AU - MacGrogan, G.

AU - Michiels, S.

AU - Negreiros, I.

AU - Offersen, B. V.

AU - Penault Llorca, F.

AU - Pruneri, G.

AU - Roche, H.

AU - Russell, N. S.

AU - Schmitt, F.

AU - Servent, V.

AU - Thürlimann, B.

AU - Untch, M.

AU - van der Hage, J. A.

AU - van Tienhoven, G.

AU - Wildiers, H.

AU - Yarnold, J.

AU - Bonnetain, F.

AU - Mathoulin-Pélissier, S.

AU - Bellera, C.

AU - Dabakuyo-Yonli, T. S.

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84949997577&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdv478

DO - 10.1093/annonc/mdv478

M3 - Comment/debate

AN - SCOPUS:84949997577

SN - 0923-7534

VL - 26

SP - 2505

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F et al. Erratum: Guidelines for time-to-event end point definitions in breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [Ann Oncol, 26, (2015), 873-879] doi: 10.1093/annonc/mdv106. Annals of Oncology. 2015 déc. 1;26(12):2505. doi: 10.1093/annonc/mdv478